0001104659-21-136408.txt : 20211109
0001104659-21-136408.hdr.sgml : 20211109
20211109174030
ACCESSION NUMBER: 0001104659-21-136408
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211109
FILED AS OF DATE: 20211109
DATE AS OF CHANGE: 20211109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirsch Arthur S
CENTRAL INDEX KEY: 0001290976
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37841
FILM NUMBER: 211393501
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
STREET 2: C/O ARALEZ PHARMACEUTICALS INC.
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kadmon Holdings, Inc.
CENTRAL INDEX KEY: 0001557142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273576929
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 833-900-5366
MAIL ADDRESS:
STREET 1: 450 EAST 29TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Kadmon Holdings, LLC
DATE OF NAME CHANGE: 20120829
4
1
tm2131118-8_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-11-09
1
0001557142
Kadmon Holdings, Inc.
KDMN
0001290976
Kirsch Arthur S
C/O KADMON HOLDINGS, INC.
450 E. 29TH STREET
NEW YORK
NY
10016
1
0
0
0
Common Stock
2021-11-09
4
D
0
30000
9.50
D
0
D
Stock Option (right to buy)
2.29
2021-11-09
4
D
0
64103
7.21
D
2029-05-15
Common Stock, par value $0.001
64103
0
D
Stock Option (right to buy)
2.29
2021-11-09
4
D
0
100000
7.21
D
2029-05-15
Common Stock, par value $0.001
100000
0
D
Stock Option (right to buy)
4.44
2021-11-09
4
D
0
85034
5.06
D
2030-05-13
Common Stock, par value $0.001
85034
0
D
Stock Option (right to buy)
3.58
2021-11-09
4
D
0
96975
5.92
D
2031-05-12
Common Stock, par value $0.001
96975
0
D
Disposed pursuant to the acquisition by Sanofi of the entire issued share capital of Issuer on November 9, 2021 by means of a plan of merger (the "Merger").
In connection with the Merger, all unvested stock options ("Options") were accelerated to full vesting and cancelled in exchange for a payment equal to $9.50 with respect to each share of Common Stock subject to such Option.
Represents the payment per share of Common Stock received in exchange for the cancellation of each Option.
/s/ Gregory S. Moss, Attorney-in-Fact
2021-11-09